Synairgen launches SG016 trial of SNG001 for Covid-19 treatment

SNG001 is an inhaled formulation of interferon-beta-1a, a natural protein associated with the body’s antiviral responses. Credit: Photo by Olga Kononenko on Unsplash.



  • Covid